372 related articles for article (PubMed ID: 3652042)
1. Syngeneic monoclonal antibodies to B16 melanoma viral antigens.
Rappaport I; Alterman AL; Braverman S; Stackpole CW
Cancer Res; 1987 Oct; 47(20):5391-6. PubMed ID: 3652042
[TBL] [Abstract][Full Text] [Related]
2. Multiple antigens related to the major envelope glycoprotein of murine leukemia virus expressed on B16 melanoma cells as targets of host immune response.
Stackpole CW; Demsey A
Invasion Metastasis; 1984; 4(1):28-46. PubMed ID: 6329988
[TBL] [Abstract][Full Text] [Related]
3. Cross-reactivity of murine anti-human high molecular weight-melanoma associated antigen monoclonal antibodies with guinea pig melanoma cells.
Liao SK; Smith JW; Kwong PC; Natali PG; Kusama M; Hamby CV; Ferrone S
Cancer Res; 1987 Sep; 47(18):4835-41. PubMed ID: 3476198
[TBL] [Abstract][Full Text] [Related]
4. Phenotypic diversity of murine B16 melanoma detected by anti-B16 monoclonal antibodies.
Johnson CW; Barth RF; Adams D; Holman B; Price JE; Sautins I
Cancer Res; 1987 Feb; 47(4):1111-7. PubMed ID: 2433032
[TBL] [Abstract][Full Text] [Related]
5. Murine tumor cell lysis by antibody-dependent macrophage-mediated cytotoxicity using syngeneic monoclonal antibodies.
Kawase I; Komuta K; Ogura T; Fujiwara H; Hamaoka T; Kishimoto S
Cancer Res; 1985 Apr; 45(4):1663-8. PubMed ID: 3978634
[TBL] [Abstract][Full Text] [Related]
6. Differential antigenic expression of the DBA/2 lymphoma L1210 and its sublines: cross-reactivity with C3H mammary tumors as defined by syngeneic monoclonal antibodies.
Rapp L; Fuji H
Cancer Res; 1983 Jun; 43(6):2592-9. PubMed ID: 6342755
[TBL] [Abstract][Full Text] [Related]
7. Poorly metastatic tumor cell variants as primary targets of syngeneic antibody responses against murine melanoma.
Parratto NP; Odebralski JM; Kimura AK
Cancer Res; 1989 Jul; 49(14):3722-8. PubMed ID: 2736512
[TBL] [Abstract][Full Text] [Related]
8. Suppression of B16 melanoma lung colonization by syngeneic monoclonal antibodies.
Herd ZL
Cancer Res; 1987 May; 47(10):2696-703. PubMed ID: 3552203
[TBL] [Abstract][Full Text] [Related]
9. Cross-reacting antigens on L5178Y cells which serve as targets for cytotoxic T-lymphocyte lysis during establishment of the tumor dormant state.
Weinhold KJ; Wheelock EF
Cancer Res; 1982 Sep; 42(9):3607-16. PubMed ID: 6179603
[TBL] [Abstract][Full Text] [Related]
10. Modulation of B16 melanoma antigen expression by lymphokines and dimethyl sulfoxide.
Trimpe KL; Zwilling BS
Cancer Res; 1986 Oct; 46(10):4953-9. PubMed ID: 3756856
[TBL] [Abstract][Full Text] [Related]
11. Expression of antigens coded in murine leukemia viruses on thymocytes of allogeneic donor origin in AKR mice following syngeneic or allogeneic bone marrow transplantation.
Wustrow TP; Good RA
Cancer Res; 1985 Dec; 45(12 Pt 1):6428-35. PubMed ID: 2998600
[TBL] [Abstract][Full Text] [Related]
12. Immunity to virus-free syngeneic tumor cell transplantation in the BALB/c mouse after immunization with homologous tumor cells infected with type C virus.
Al-Ghazzouli IK; Donahoe RM; Huang KY; Sass B; Peters RL; Kelloff GJ
J Immunol; 1976 Dec; 117(6):2239-48. PubMed ID: 186539
[TBL] [Abstract][Full Text] [Related]
13. [Monoclonal antitumor antibodies--its application to diagnosis and treatment of tumors].
Taniguchi M; Wakabayashi S
Gan No Rinsho; 1983 May; 29(6):654-8. PubMed ID: 6876435
[TBL] [Abstract][Full Text] [Related]
14. Identification of a viral antigen recognized by H-2-restricted cytolytic T lymphocytes on a murine leukemia virus-induced tumor.
Plata F; Kalil J; Zilber MT; Fellous M; Lévy D
J Immunol; 1983 Nov; 131(5):2551-6. PubMed ID: 6605389
[TBL] [Abstract][Full Text] [Related]
15. High levels of Met-72 antigen expression: correlation with metastatic activity of B16 melanoma tumor cell variants.
Kimura AK; Xiang JH
J Natl Cancer Inst; 1986 Jun; 76(6):1247-54. PubMed ID: 3486997
[TBL] [Abstract][Full Text] [Related]
16. Surface antigens of melanomas and melanocytes defined by mouse monoclonal antibodies: specificity analysis and comparison of antigen expression in cultured cells and tissues.
Real FX; Houghton AN; Albino AP; Cordon-Cardo C; Melamed MR; Oettgen HF; Old LJ
Cancer Res; 1985 Sep; 45(9):4401-11. PubMed ID: 4028024
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibody recognizing human melanoma-carcinoma cross-reacting oncofetal antigen epitopically associated with carcinoembryonic antigen.
Liao SK; Kwong PC; Clarke BJ; Dent PB; Ryan ED; Khosravi MJ; Laferte S; Krantz MJ
J Natl Cancer Inst; 1985 May; 74(5):1047-58. PubMed ID: 2582173
[TBL] [Abstract][Full Text] [Related]
18. Studies of a high molecular weight human melanoma-associated antigen.
Hellström I; Garrigues HJ; Cabasco L; Mosely GH; Brown JP; Hellström KE
J Immunol; 1983 Mar; 130(3):1467-72. PubMed ID: 6822741
[TBL] [Abstract][Full Text] [Related]
19. Characterization of two human small cell lung carcinoma-reactive monoclonal antibodies generated by a novel immunization approach.
Tong AW; Lee J; Stone MJ
Cancer Res; 1984 Nov; 44(11):4987-92. PubMed ID: 6207911
[TBL] [Abstract][Full Text] [Related]
20. [An analysis of gp 70 expressed on Friend virus-infected rat tumor cells and the mouse melanoma antigen cross-reacting with it].
Furune T
Hokkaido Igaku Zasshi; 1991 Sep; 66(5):665-76. PubMed ID: 1959842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]